Mesoblast Statistics

Total Valuation

Mesoblast has a market cap or net worth of $1.73 billion. The enterprise value is $1.78 billion.

Market Cap	1.73B
Enterprise Value	1.78B

Important Dates

The last earnings date was Wednesday, August 28, 2024, after market close.

Earnings Date	Aug 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Mesoblast has 1.14 billion shares outstanding. The number of shares has increased by 26.87% in one year.

Current Share Class	n/a
Shares Outstanding	1.14B
Shares Change (YoY)	+26.87%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	640.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	20.84
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	301.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.18, with a Debt / Equity ratio of 0.25.

Current Ratio	1.18
Quick Ratio	1.14
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2.81

Financial Efficiency

Return on equity (ROE) is -17.91% and return on invested capital (ROIC) is -5.95%.

Return on Equity (ROE)	-17.91%
Return on Assets (ROA)	-5.41%
Return on Capital (ROIC)	-5.95%
Revenue Per Employee	$80,849
Profits Per Employee	-$1.20M
Employee Count	73
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	-191,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +590.09% in the last 52 weeks. The beta is 2.34, so Mesoblast's price volatility has been higher than the market average.

Beta (5Y)	2.34
52-Week Price Change	+590.09%
50-Day Moving Average	10.45
200-Day Moving Average	7.52
Relative Strength Index (RSI)	64.37
Average Volume (20 Days)	552,787

Short Selling Information

Short Interest	1.42M
Short Previous Month	1.68M
Short % of Shares Out	1.58%
Short % of Float	n/a
Short Ratio (days to cover)	6.69

Income Statement

In the last 12 months, Mesoblast had revenue of $5.90 million and -$87.96 million in losses. Loss per share was -$0.09.

Revenue	5.90M
Gross Profit	-35.17M
Operating Income	-57.97M
Pretax Income	-73.25M
Net Income	-87.96M
EBITDA	-56.08M
EBIT	-57.97M
Loss Per Share	-$0.09

Full Income Statement

Balance Sheet

The company has $62.96 million in cash and $118.92 million in debt, giving a net cash position of -$55.96 million or -$0.05 per share.

Cash & Cash Equivalents	62.96M
Total Debt	118.92M
Net Cash	-55.96M
Net Cash Per Share	-$0.05
Equity (Book Value)	480.36M
Book Value Per Share	0.42
Working Capital	13.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$48.46 million and capital expenditures -$271,000, giving a free cash flow of -$48.73 million.

Operating Cash Flow	-48.46M
Capital Expenditures	-271,000
Free Cash Flow	-48.73M
FCF Per Share	-$0.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-982.24%
Pretax Margin	-1,493.51%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mesoblast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.87%
Shareholder Yield	-26.87%
Earnings Yield	-5.09%
FCF Yield	-2.82%

Analyst Forecast

The average price target for Mesoblast is $13.50, which is -7.72% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$13.50
Price Target Difference	-7.72%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	155.51%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 10, 2024. It was a reverse split with a ratio of 0.5:1.

Last Split Date	Jan 10, 2024
Split Type	Reverse
Split Ratio	0.5:1

Scores

Mesoblast has an Altman Z-Score of -0.92 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.92
Piotroski F-Score	3